Capsule Endoscopy Market: Rapidly Evolving Industry…… COVID-19….
Global capsule endoscopy
market is expected to reach USD 886.3 million by 2022; according to
a new study by Grand View Research, Inc. Increasing prevalence of colorectal
cancer, GI diseases and growing demand for precise and accurate diagnostic
tools are expected to drive the capsule endoscopy market over the forecast
period. According to a report published by the World Cancer Research Institute,
about 54.0% of colorectal cancer cases occurred in developed countries and the
number is expected to grow exponentially over the decade. The introduction of
technologically advanced features such as WiFi enabled small bowel capsules
featuring longer battery life are further expected to drive the demand for
capsule endoscopy devices. Presence of favorable government initiatives are
expected to play an imperative role in determining market trends over the
forecast period. For instance, initiatives such as the DCPC’s National
Comprehensive Cancer Control Program (NCCCP) in the U.S. aimed at increasing
patient awareness levels pertaining to colorectal cancer screening is expected
to boost usage rates during the forecast period.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
Global capsule endoscopy market is
expected to experience lucrative growth over the forecast period due to, the
rising prevalence of gastrointestinal diseases, colorectal cancer, demand for
faster and accurate diagnostics tools, and the presence of supportive
government initiatives. Capsule endoscopy provides painless visualization of GI
(gastrointestinal) tract images, transmitted via data recorder. Additionally,
the introduction of technologically advanced capsules such as longer battery
life and WiFi enabled are expected to further drive the growth of the capsule
endoscopy market. The global capsule endoscopy market was valued at USD 454.7
million in 2014 and is expected to grow at a CAGR of 8.7% over the forecast
period.
Increasing
global geriatric population base is further expected to provide this market
with a strong growth platform over the next seven years. Aging increases the
risk of GI disorders such as CRC, inflammatory bowel disease, and appendicitis.
According to the W.H.O, global population base pertaining to the age group – 65
years and above is expected to rise from 7% in 2000 to 16% in 2050. This is
expected to significantly improve the patient base, thereby, driving the growth
of the capsule endoscopy market.
To Request Sample Copy of this report, click the link:
The capsule endoscopy market is analyzed by
segmenting the market into small bowel capsule, esophageal capsule, and colon
capsule. As of 2014, small bowel capsule held the largest market share, owing
to its increasing usage in multiple medical conditions such as small bowel
neoplastic lesions, inflammatory bowel disease, suspected Crohn’s disease and
obscure GI tract bleeding. On the other hand, colon capsule segment is expected
to register lucrative market growth over the forecast period. As stated by the
CDC, every year colorectal cancer causes nearly 608,000 fatalities globally and
over 14.5 million colonoscopies are performed. Additionally, growing demand for
less invasive diagnosis platform are some key factors supporting the
aforementioned conclusion.
Further key findings from the study suggest:
·
Wireless capsules dominated the
accessory market in 2014 and are also expected to register lucrative growth
over the forecast period. Increasing usage rates of colon, small intestine and
esophageal screening is expected to drive segment growth. In addition, presence
of supportive reimbursement policies and the introduction of technologically
advanced products are expected to serve this market as future growth
opportunities.
·
Small bowel endoscopy capsule
was the leading product segment of the market in 2014. These devices find wide
applications in treating diseases such as suspected Crohn’s disease,
inflammatory bowel disease, obscure GI tract bleeding and small bowel
neoplastic lesions and this is expected to serve the segment as a high impact
rendering driver. Increasing prevalence of target diseases is also expected to
make significant contributions towards market growth.
·
Capsule endoscopy finds the
largest application in OGIB (Obscure gastrointestinal bleeding) diagnosis owing
to, increasing usage of wireless capsule endoscopes in vascular and
inflammatory lesion diagnoses
·
North America was the largest
regional capsule endoscopy market in 2014. The region’s market position is
attributed to by factors such as presence of sophisticated healthcare
infrastructure, supportive reimbursement policies and growing adoption rates of
minimally invasive surgeries.
·
Asia Pacific region is anticipated
to register rapid growth over the forecast period owing to, factors such as the
presence of high unmet needs with respect to colorectal screening, rising
disposable income and patient awareness levels and improving healthcare
infrastructure
·
Key market players of the
capsule endoscopy market include RF System lab, Olympus Corporation, Chongqing
Jinshan Science & Technology (Group) Co., Given Imaging, Ltd., Fujifilm
Holding Corporation, IntroMedic Co., Ltd and CapsoVision.
Wireless capsule was the leading application
segment of the capsule endoscopy market in 2014. The increasing usage rate of
wireless capsules in the small intestine, esophagus and colon and the presence
of favorable reimbursement policies are some high impact rendering drivers of the
wireless capsule endoscopy market. Technologically advanced capsules with
inbuilt features such as 360-degree panoramic view, greater battery life,
enhanced data storage capability, easy transmission and larger frame rate are
expected to provide the wireless capsule market with lucrative future growth
opportunities.
Obscure gastrointestinal bleeding (OGIB) was
one of the leading application segments of the capsule endoscopy market in
2014. According to a research study conducted by the U.S. National Library of
Medicine, capsule endoscopy was found to be more effective than barium X-rays
used for investigation of OGIB. Capsule endoscopy is widely used for diagnosis
of occult bleeding in the duodenum as well as the diagnosis of Crohn’s disease
and small bowel tumors. Additionally, owing to the advantages attached such as
real-time visualization of the entire small intestine and faster & easier
diagnosis, healthcare professionals, and patients are shifting their preference
from conventional methods such double balloon enteroscopy to capsule endoscopy,
which is expected to provide substantial growth platform to this market segment
in near future. Crohn’s disease application market being in sync with the OGIB
segment is expected to experience growth due to increasing prevalence rate of
target disease coupled with adoption as preferred diagnosis method.
Have any Query? Ask our Experts:
Grand View Research has segmented the
global capsule endoscopy market on the basis of accessory, product,
application:
Global Capsule Endoscopy Accessories Outlook (Revenue,
USD Million, 2012 - 2022)
·
Wireless capsule
·
Workstation and receiver
Global Capsule Endoscopy Product Outlook (Revenue, USD
Million, 2012 - 2022)
·
Small bowel
·
Esophageal
·
Colon
Global Capsule Endoscopy Application Outlook (Revenue,
USD Million, 2012 - 2022)
·
OGIB
·
Crohn’s disease
·
Small Intestine tumor
·
Others (Celiac, NSAID
reactions)
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment